Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An erythroid differentiation gene expression signature predicts response to lenalidomide in myelodysplasia

Ebert B, Galili N, Tamayo P, Mak R, Pretz J, Ladd-Acosta C, Stone R, Golub T, Raza A. An erythroid differentiation gene expression signature predicts response to lenalidomide in myelodysplasia. Blood. 2006; 108:754a.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.